Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Development
Female hormone product development completed; distribution contracted
August 18th, 2005
Interpharm Holdings, Inc., (IPA) announced that it has completed the development of a female hormone product. This product, which requires a dedicated facility and specialized handling, will be exclusively distributed by Centrix Pharmaceutical, Inc. Pursuant to a multiyear contract, Centrix has committed to purchase $11.5 million of the product during the first year. Interpharm plans to commence shipment of the product within a month. This product marks the beginning of the execution of Interpharm's recently implemented 4-year business plan. This plan will shift Interpharm's focus from commodity type products with gross margins typically in the low...
Source: Women's Health Weekly (2005-08-18)
|
